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While seeming like a recent discovery, celiac disease 
was believed to be first described around the First Century 
A.D. by the Greek physician Arataeus, who referred to celiac 
disease as an intestinal disorder associated with 
malabsorption and diarrhea (Sollid & Jabri, 2013). In the 
1940s, Dutch pediatrician William-Karel Dicke, discovered 
that celiac disease was caused by the consumption of cereal 
gluten proteins (Sollid & Jabri, 2013). Today scientists and 
healthcare providers have a much larger knowledge base on 
celiac disease. However, due to the considerable symptom 
variance among patients, celiac disease may still go 
undiagnosed or be mistaken for another disease process.
• Patients with celiac disease may wait as long as 11 years 
before a correct diagnosis is made (Reinhardt & Yancon, 
2012).
• About one-third of patients have been previously 
diagnosed with irritable bowel syndrome (Reinhardt & 
Yancon, 2012). 
• Celiac disease has become the most common 
autoimmune inherited disorder (Bacigalupe & Plocha, 
2015). 
• Approximately 1% of the U.S. population is affected by 
celiac disease (Bacigalupe & Plocha, 2015). 
• Non-Hispanic whites have the highest incidence rate of 
1%, signifying that at least 1.7 million in this population 
have celiac disease, compared to the national average of 
0.71% (Mistler, 2015). 
• Disease onset typically occurs between 6 months to 2 
years of age after gluten has been introduced, or 
between 20 to 40 years of age (Reinhardt & Yancon, 
2012). 
• Celiac disease can range from asymptomatic to 
malabsorption in severe cases.
Celiac disease occurs in genetically predisposed 
individuals, and is triggered by the ingestion of gluten 
(Bacigalupe & Plocha, 2015). Gluten is a protein found in 
wheat, barley, and rye products. Ingestion of gluten triggers 
an immune reaction, which causes damage to the small 
intestinal mucosa (Walter, 2013). Intestinal villi, the 
fingerlike projections of the small bowel mucosa become 
partially or completely atrophied from gluten ingestion in 
these genetically predisposed individuals, which leads to 
malabsorption, possible weight loss, and risk of 
malnutrition (Sollid & Jabri, 2013). The only treatment for 
celiac disease is a life-long gluten free diet, which will allow 
intestinal mucosa to heal over time. Diagnostic serology 
must be completed before gluten is eliminated from the 
diet to obtain accurate results.
As a future family nurse practitioner, digestive disorders 
are among a long list of conditions patients may seek care 
for. In recent years celiac disease is a digestive disorder that 
has received much attention from both patients and the 
healthcare community. Only through proper education will 
healthcare professionals be able to understand common 
symptoms, pathophysiology, and diagnostic tools of celiac 
disease, which will in turn allow patients to be correctly 
instructed and diagnosed in a timely manner.
Pathophysiology
• Celiac disease is a digestive disorder that occurs when an 
individual’s immune system overreacts to the protein 
gluten (Ulbricht, 2013). 
• Wheat, rye, and barley glutens are the main offenders of 
the disease (Mistler, 2015).
• Villous atrophy is the hallmark sign of celiac disease.
• The exact mechanisms of the disease process are still 
being studied.
According to Mistler (2015), “proline- and glutamine-rich 
residues compose the protein subunits of gliadins and 
glutenins which make up the wheat, rye and barley glutens” 
that are the main offenders of the disease (p. 213). This 
pathophysiology is significant, as a large portion of most 
diets consist of grains, especially wheat. An increased 
amount of interferon-γ (INFγ) is secreted by CD4+ αβ T cells, 
coded for by the HLA-DQ2 variant 2.5 and HLA-DQ8 genes, as 
they become sensitized to these gluten proteins after 
translation modification deamidation by transglutaminase 
(Mistler, 2015). HLA-DQ2 and HLA-DQ8 molecules are only 
responsible for approximately 40% of genetic predisposing 
factors in the pathogenesis of celiac disease, which is 
necessary but not sufficient to cause disease, and therefore 
“many more risk loci outside the HLA region should be 
identified as disease markers” (Huang et al., 2017, p. 2). 
Transglutaminase is the primary autoantigen seen in 
celiac disease, and is an enzyme responsible for 
transamination, or cross-linking, and deamination of 
glutamine residues, such as gluten (Mistler, 2015). Villous 
atrophy, is the “histomorphologic hallmark of celiac disease” 
(Shalimar, Das, Sreenivas, Gupta, Panda & Makharia, 2013, p. 
1262). Villous atrophy occurs due to sensitization, allowing T 
cell infiltration of the mucosa. This leads to damage, villous 
atrophy, crypt hyperplasia and eventual activation of B cells 
which produce IgA antibodies to gliadin, endomysium and 
transglutaminase (Mistler, 2015). 
The precise trigger of this reaction has not been 
determined, however, it is associated with autoimmune 
disorders, such as systemic lupus erythematosus (Ulbricht, 
2013). Autoimmune disorders occur when a patient’s 
immune system mistakenly identifies body cells as harmful 
invaders and as a result, the immune cells in a patient with 
celiac disease attack that patient’s intestinal cells (Ulbricht, 
2013). According to Shalimar et al., (2013), villous atrophy 
could occur due to increased cell destruction or enhanced 
apoptosis and/or a defect in epithelial cell regeneration. 
Damage to intestinal villi can then lead to malabsorption and 
malnutrition in severe cases. 
Signs and Symptoms
Celiac disease can present with a wide array of signs and symptoms and may be 
affected by the patients age and other illnesses. Patients with celiac disease may present 
with various vitamin and mineral deficiencies due to intestinal damage. The most 
common deficiencies are vitamin D, calcium, folate, vitamin B12 and iron (Jurgelewicz, 
2015). While celiac disease may result in a wide range of complications the most serious 
are failure to thrive and even lymphoma if celiac disease goes untreated or undiscovered 
long enough. According to Mistler (2015), there are four main presentations of celiac 
disease that have been determined by a task force of physicians from seven different 
countries:  1) classic, 2) non-classic, 3) subclinical, and 4) potential.
Classic
• Pediatric patients may present with: chronic diarrhea, vomiting, anorexia, abdominal 
pain and distention, decreased weight gain, weight loss, or nutritional deficiency 
(Mistler, 2015). 
• Nutritional deficiency in the pediatric population, can lead to growth and 
psychomotor delays, rickets, and other hematological symptoms, while infants may 
present with severe diarrhea, dehydration, lethargy, and marked abdominal 
distention, which left untreated or undiagnosed can cause severe malnutrition 
(Mistler, 2015). 
• Adults may present with constipation, nausea, loss of appetite, or intermittent 
diarrhea (Mistler, 2015). 
Non-classic
• “Non-classic celiac disease does not manifest with typical gastrointestinal distress and 
may account for as much as 70% of  cases” (Mistler, 2015, p. 213).
• Most of the symptoms are due to the nutritional deficiency that results from 
malabsorption in the small intestines due to villous atrophy, seen in the majority of 
pediatric cases, or in anemia in the teenage and young adult population (Mistler, 
2015). 
• Intestinal manifestations are usually mild gastrointestinal distress.
• Extra-intestinal manifestations include: anemia, height and weight deficiency, failure 
to thrive, delayed puberty, dermatitis herpetiformis, dental enamel hypoplasia, iron 
deficiency anemia resistant to oral therapy, low bone mineral density, liver 
dysfunction, neurologic disorders of depression, anxiety, autism, peripheral 
neuropathy, cerebral ataxia, epilepsy and migraines (Mistler, 2015). 
Subclinical
• In subclinical celiac disease, many patients already suffer from another autoimmune 
disease such as diabetes type 1, thyroiditis, psoriasis, or genetic conditions such as 
Downs Syndrome, Turners Syndrome, and IgA deficiency (Mistler, 2015). 
• Subclinical celiac disease is rare and patients usually do not display any signs or 
symptoms.
Potential
• Patients may exhibit constipation, nausea, loss of appetite, or intermittent diarrhea, 
but serology and biopsy results are negative for celiac disease (Mistler, 2015). 
Diagnosis
• The serological tests used for detecting celiac disease include: detection of 
anti-tTG antibodies (a-tTG), antiendomysial antibodies (EMA), and 
antigliadin antibodies (AGA) (Porcelli, Ferretti, Vindigni, & Terzuoli, 2016). 
• The usually accepted first choice test is detection of IgA a-tTG, which 
displays the highest level of sensitivity (up to 98%) with excellent 
reproducibility (Porcelli et al., 2016). 
• According to Mistler (2015) Anti-deamidated gliadin peptide should be 
paired with both the total serum IgA and anti-tissue transglutaminase IgA 
and IgG for screening symptomatic patients on a diet containing gluten for 
best diagnosis. 
• “Patients that test positive by deamidated gliadin peptide and/or anti-
tissue transglutaminase should then be confirmed with HLA typing and/or 
biopsy and started on a gluten-free diet” (Mistler, 2015, p. 214). 
• Measurements of antibodies to AGA IgA and IgG, TTG IgA and IgG, ARA IgA, 
EMA IgA by immunoassay and/or immunofluorescence and testing levels 
of total IgA include current laboratory choices (Mistler, 2015). 
• Genetic testing for HLA-DQ2.5 and HLA-DQ8 haplotypes may be seen as an 
essential second step in diagnosis (Mistler, 2015).
• The gold standard for diagnosis is biopsy of the small intestine, in which 
upper gastrointestinal endoscopy is used for obtaining biopsies and should 
include a minimum of 4 biopsies with two from the distal duodenum and 
two from the bulbus (Mistler, 2015).
Nursing Care
• Healthcare professionals play an essential role in providing adequate 
education and support to patients and their families.
• Patients will need to be taught how to identify gluten-free products and 
how to accurately read food labels. 
• Gluten may be used as a stabilizer, emulsifier, and thickening agent in an 
array of processed foods (O’Donnell, 2016).
• “Many foods are naturally gluten-free, including fresh meats, poultry and 
fish; eggs; fruits and vegetables; rice; potatoes; milk and cheese; and beans, 
seeds and nuts in their natural form” (Celiac disease, 2015). 
• Patients should also be taught about gluten-free flour options: rice flour, 
potato starch flour, tapioca starch flour or cornstarch (Celiac disease, 2015). 
• Some vitamins and medications may also contain gluten, patients should be 
encouraged to talk with their local pharmacist to be sure medications do not 
contain gluten (Celiac disease, 2015).
• Some patients may be at risk for vitamin and mineral deficiencies, including 
B vitamins, calcium, vitamin D, and iron (Celiac disease, 2015). 
• Some patients may need to take a multivitamin or supplement or working 
closely with a dietician, a proper gluten free diet can be determined to meet 
nutritional needs (Celiac disease, 2015). 
• A multidisciplinary approach carries the highest rate of patient success.
• Nurses need to collaborate with a dietician to teach patients and their 
families how to eat a balanced diet and adapt to a gluten-free diet with 
minimal added expense (O’Donnell, 2016). 
• The topic of eating out should also be covered, many restaurants now offer 
gluten-free options and menus (O’Donnell, 2016). 
• Cross contamination both at home and when eating out is a topic that 
should be covered. 
• Patients can also be referred to support groups, as patients can support 
each other in transitioning to and maintaining a gluten-free diet, become 
educated about the disease, and share information on available resources 
(O’Donnell, 2016). 
• Patients must be encouraged to continue to follow-up with their healthcare 
providers, as patients with celiac disease are at higher risk for other 
autoimmune diseases.
• Yearly serologic testing should be completed to ensure that adhering to the 
gluten-free diet is effective (O’Donnell, 2016). 
• Other testing could include bone-density testing, testing for nutritional 
deficiencies, and also for possible malignancies (O’Donnell, 2016).
• Patients may also be referred to specialists or gastroenterologists for 
further testing. 
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Conclusion
Celiac disease is becoming a more prevalent 
disease and deserves more attention by healthcare 
professionals. Patients of all ages are affected by the 
disease and therefore it is essential healthcare 
professionals examine all signs and symptoms closely. 
Being familiar with the disease process and possible 
genetic components is important to proper patient 
care and diagnosis. Celiac disease is not always easy 
to diagnose and may be misdiagnosed several times 
before a proper diagnosis is confirmed. Adequate 
education and support is essential to patient’s 
lifelong commitment to a gluten free diet and healthy 
life. 
(Drummond, n.d.)
Dermatitis herpetiformis caused by celiac disease.
(Dermatitis herpetiformis, 2014)
